it makes this story much more amazing- if it proves out. B not initially touted as antiviral, not tried for SARS or MERS so far as we know, and yet someone had the foresight to suggest that Leo send some B to an RBL for testing. They sent him some papers about viruses and defenses na d about defenses and vaccines. Those are put up on the site for March update to shareholders.
Then some tests start- but the vaccine stuff is dropped fairly quickly per IP PR
Initial data from RBL unimpressive and then we have the June 17 bomb!
We have no details yet and people say- not a word till publication. Oh really? How about the 94 and 97 % info- without details of course.
Maybe not dumb luck, but perhaps a miracle - waiting for the human trials
please fill in blanks as you understand them- Cavasotto article in one such blank obv, its meaning not yet clear.
Market Data 
Markets 
AI
